Key result
The AAP2017 and ESHG2016 guidelines showed substantial agreement for diagnosing hypertension in adolescents, with overall hypertension frequencies of 34.4% and 32.4%, respectively.
Why the study?
Hypertension diagnosis criteria in adolescents aged ≥13 and <16 years differ between the percentile-based ESHG guideline and the single-criterion AAP guideline, prompting an evaluation of their compatibility.
Does the AAP2017 guideline agree with the ESHG2016 guideline in diagnosing hypertension in adolescents aged 13 to 16 years?
Observational (n=395)
No
Does the AAP2017 guideline agree with the ESHG2016 guideline in diagnosing hypertension in adolescents aged 13 to 16 years?
Both the AAP2017 and ESHG2016 guidelines demonstrate substantial agreement and can be used for diagnosing hypertension in adolescents aged 13 to 16 years.
Answers are grounded in this paper and cite their sources.
Substantial agreement between ESH and AAP guidelines supports interchangeable use in adolescents; leaves open prospective outcome studies before practice change.
OBJECTIVE: The diagnosis of hypertension in adolescents aged ≥13 and <16 years is based on the percentile according to age, gender, and height in the European Society of Hypertension guidelines guideline; whereas, the American Academy of Pediatrics guideline uses blood pressure above 130/80 mmHg as a single criterion. Therefore, this study aimed to evaluate the compatibility of these two guidelines in adolescents aged ≥13 and <16 years. METHODS: This study was designed by retrospectively screening the records of 395 adolescents with both office and 24-hour ambulatory blood pressure measurements. Each blood pressure measurement was classified according to both the ESGH2016 and AAP2017 guidelines. Patients were divided into three subgroups according to body mass index. Cohen's kappa analysis was used to evaluate the agreement between the two guidelines. RESULTS: The majority of adolescents were normotensive according to both guidelines, 55.9% by ESHG2016 and 43.1% by AAP2017. For the whole group, the frequency of hypertension was 32.4% with ESHG2016 and 34.4% with AAP2017; while, in obese patients, hypertension frequencies were 38.8% and 43.3%, respectively. The diagnosis of hypertension was demonstrated with the two guidelines, and there was significant agreement at a substantial level, both for the obese subgroup and the whole study group (kappa value = 0.738 and 0.785, respectively). The frequency of white-coat hypertension was higher with the AAP2017 guideline (28.1% versus 16.2%, p < 0.001). CONCLUSION: With our experience in this single-centre study, it seems that both the AAP2017 and the ESHG2016 guidelines can be used in the diagnosis of hypertension in adolescents.
No takes yet. Share an insight, caveat, or question.
A 2021 study conducted an observational in hypertension (n=395). AAP2017 guideline criteria vs. ESHG2016 guideline criteria was evaluated on Frequency of hypertension diagnosis and agreement between guidelines (kappa 0.785). The AAP2017 and ESHG2016 guidelines showed substantial agreement for diagnosing hypertension in adolescents, with overall hypertension frequencies of 34.4% and 32.4%, respectively.
Synapse has enriched 10 related papers. Consider them for comparative context: